Fig. 4From: Promoting collateral formation in type 2 diabetes mellitus using ultra-small nanodots with autophagy activation and ROS scavengingMoS2 NDs improved collateral formation in diabetic mice. (A) Illustration of time points of MoS2 NDs injection and laser Doppler imaging in diabetic mice. (B) Representative H&E images of muscles harvested at the indicated time with PBS and MoS2 NDs. (C) Quantification of the regenerating area at different time points, n = 5, and P values were calculated by two-way ANOVA with Bonferroni post-hoc test. (D) Quantification of the necrotic area at indicated times from H&E staining, n = 5, and P values were calculated by two-way ANOVA with Bonferroni post-hoc test. (E) Representative images of hindlimb blood perfusion with PBS and MoS2 NDs at indicated times. (F) Quantification of hindlimb blood perfusion at the indicated times, n = 5, and P values were calculated by two-way ANOVA with Bonferroni post-hoc test. (G) Representative DHE staining images and quantification of DHE+ area on day 7, n = 9, P values were calculated by t-test. (H) Representative CD31+/α-SMA+ immunofluorescent images and quantification of CD31+ area and α-SMA area on transverse cross sections on day 7, n = 9, and P values were calculated by t-test. All data are presented as the mean ± SD.Back to article page